NEW

FDA clears first fully disposable duodenoscope, eliminating the potential for infections caused by ineffective reprocessing

The U.S. Food and Drug Administration today cleared for marketing in the U.S. the first fully disposable duodenoscope. The EXALT Model D Single-Use Duodenoscope is intended to provide visualization and access to the upper gastrointestinal (GI) tract to treat bile duct...

Webinar Addresses ‘Hot Topic’

The recent OR Today webinar “Human Factors and Quality Testing for Device Reprocessing” was sponsored by Healthmark and eligible for one (1) continuing education (CE) hour by the State of California Board of Registered Nursing. The 60-minute webinar featured Jahan...

Nihon Kohden Introduces First Subscription-Based Pricing for Patient Monitoring, Neurology Products

Nihon Kohden, a U.S. market leader in precision medical products and services, has launched subscription-based pricing models for its patient monitoring and neurology products, the first in the industry to take such a step. The pricing models help align costs with...

Nihon Kohden Launches Life Scope SVM-7200 Series

Nihon Kohden has announced the launch of its Life Scope SVM-7200 Series vital signs monitor, a monitor designed for outpatient facilities and beds that traditionally are not continuously monitored. The monitor allows health care practitioners to quickly and easily...

PRIMUS Sterilizer names Jim Fry as CEO

PRIMUS Sterilizer Board of Directors has appointed Jim Fry as Chief Executive Officer and a member of the Board of Directors. Fry brings with him experience in the life science and health care industry. He has led and been a member of executive teams that developed global solutions for customers in the key segments that PRIMUS operates in.

Prior to joining PRIMUS, Fry held multiple roles within Getinge including President of LANCER USA, SVP Getinge North America, and a member of Getinge’s Portfolio Decision Board that was responsible for all product life cycle decisions inside the Infection Control Division of the Getinge Group. His last position with Getinge was head of its newly formed Life Science business unit with P&L responsibility for the Americas region as well as a member of the global Life Science Management team.

Former CEO Michael Douglas is stepping down after six years with PRIMUS. During his tenure at PRIMUS, he successfully led the company through numerous facility consolidation initiatives and greatly expanded the operating margins of the business. Douglas will assist Fry during a transition period.

PRIMUS is a portfolio company of Blue Sage Capital, an Austin, Texas-based private equity firm with $250 million of assets under management.

“We are very appreciative of Michael’s leadership at PRIMUS and thank him for his hard work,” said Blue Sage co-founding partner Peter Huff. “We are thrilled to have Jim join the PRIMUS family and believe his extensive background in the industry will serve him well as he leads the company. Jim is a proven leader with a vision for PRIMUS. Both Blue Sage and Jim believe PRIMUS is a market leader in the steam sterilizer industry and we look forward to a successful partnership with Jim.”•

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X